Advances in exosomes utilization for clinical applications in cancer

Area of Science:

• Oncology
• Nanotechnology
• Biochemistry

Background:

• Exosomes are emerging as critical players in intercellular communication.
• Their potential in clinical applications, particularly in oncology, is significant.
• Exosome-based diagnostics and therapeutics are rapidly advancing.

Purpose of the Study:

• To review the latest advancements in exosome research for cancer care.
• To highlight the clinical potential of exosomes in diagnostics and therapeutics.
• To underscore the revolutionary impact of exosomes on cancer treatment strategies.

Main Methods:

• Review of current clinical trials and research studies on exosomes in oncology.
• Analysis of exosome applications in liquid biopsies for cancer detection and monitoring.
• Examination of engineered exosomes for targeted drug delivery and immunotherapy.

Main Results:

• Exosome-based liquid biopsies demonstrate noninvasive early cancer detection and disease monitoring capabilities.
• Clinical trials are validating exosomal biomarkers for improved diagnostic accuracy and treatment response prediction.
• Engineered exosomes show potential for targeted tumor delivery, enhancing efficacy and reducing toxicity.
• Exosomes' immunomodulatory properties are being leveraged to enhance antitumor immune responses.

Conclusions:

• Exosomes hold transformative potential for revolutionizing cancer care.
• Exosome-based approaches offer promising avenues for noninvasive diagnostics and effective cancer therapies.
• Continued research and clinical trials are essential to fully realize the clinical utility of exosomes in oncology.